Pharma company Viiv’s attempt to secure patents for key HIV drugs dolutegravir and cabotegravir opposed in India
‘Patent opposition’ seeks to ensure availability of affordable generics
Last updated 10 February 2016
1Drugs for Neglected Diseases initiative R&D costs. Figures in UK£ converted from euros: http://www.dndi.org/media-centre/press-releases/1711-dndi-rd-model.html
December 22, 2015 — Doctors Without Borders/Médecins Sans Frontières (MSF) welcomes the U.S. government's "Action Plan" to scale-up drug-resistant tuberculosis (DR-TB) treatment in top-burden countries...
Last updated 22 December 2015
MSF reaction to announcement of Merck and Gavi, the Vaccine Alliance for future Ebola outbreak preparedness
Geneva, 20 January 2016 - Pharmaceutical company Merck (Merck Sharp & Dohme -- MSD) and Gavi, The Vaccine Alliance, announced an agreement today at the World Economic Forum in Davos for an Advance...
Last updated 18 January 2016
January 12, 2016 The international medical humanitarian organization Doctors Without Borders/Médecins Sans Frontières (MSF) is gravely concerned about the impact that the Trans-Pacific Partnership...
[UPDATED] End of Ebola outbreak in West Africa: World must learn lesson for future outbreaks, says MSF
Last updated 14 January 2016
The percentage of immunised children in Central African Republic (CAR) has fallen sharply since the crisis began in 2013. Médecins Sans Frontières (MSF) is now planning to vaccinate one quarter of...
Last updated 13 January 2016